This site is intended for healthcare professionals
Drug news

Phase III study of Nexavar (Bayer HealthCare) meets primary endpoint in patients with Thyroid Cancer

Read time: 1 mins
Last updated:4th Jun 2013
Published:4th Jun 2013
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest